Test Price
2,800 AED✅ Home Collection Available
SLC35C1 Gene Glycosylation Disorder Type 2C Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accurate Genetic Diagnosis for Congenital Disorder of Glycosylation Type IIc (CDG IIc)
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity through ISO 9001:2015 accredited processing and NGS technology.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed physician.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731. Pre-approval assistance available.
DNA Labs UAE | DHA Facility License No. 1143 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)
Test Overview & Methodology
This advanced Next-Generation Sequencing (NGS) test examines the entire coding region of the SLC35C1 gene to detect pathogenic variants causative of congenital disorder of glycosylation type IIc (CDG IIc), a rare metabolic condition. The test is designed to confirm the genetic diagnosis with the highest accuracy in compliance with DHA standards.
| Feature | Our Test (DHA-Compliant) | Standard Alternative |
|---|---|---|
| Methodology | NGS (Next-Generation Sequencing) with full gene coverage | Sanger sequencing of selected exons only |
| Turnaround Time | 3–4 Weeks | 5–6 Weeks |
| Sample Collection | VIP Home Collection with cold-chain (8 AM – 11 PM, ISO 9001:2015) |
In-clinic draw only |
| Post-Test Support | Free telephonic clinical guidance by DHA-licensed consultant | Report only, no interpretation session |
Physician Insight & Safety Protocols
“ Genetic testing is a powerful diagnostic tool, yet it must always be correlated with clinical history and physical findings. As a DHA-licensed consultant in medical genetics, I emphasize that a negative result does not completely rule out the disorder; follow-up with a metabolic specialist is essential. Your well-being is our utmost priority—please never self-interpret genetic data. ” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID: 9294403
Advisories and Medication Safety
⚠ Medication & Safety Warning
Do not discontinue any prescribed medication or supplement without consulting your doctor. This genetic test does not replace ongoing medical care.
Exclusion Criteria and Emergency Red Flags
Exclusion Criteria:
- Severe hemophilia or bleeding disorders that contraindicate venipuncture.
- Current use of high-dose anticoagulants (e.g., warfarin, enoxaparin) without physician clearance for a temporary pause.
- Acute febrile illness or active infection on the day of collection—reschedule after recovery.
Emergency Red Flags:
- Seek emergency care if: excessive bleeding, fainting, or signs of infection (redness, swelling, fever) occur after blood draw.
Patient FAQ & Clinical Guidance
1. What is the SLC35C1 gene test for?
This test identifies pathogenic variants in the SLC35C1 gene responsible for congenital disorder of glycosylation type IIc (CDG IIc), enabling accurate diagnosis and management of the condition.
2. How is the sample collected?
We offer home blood collection by DHA-licensed phlebotomists with cold-chain transport to ensure DNA sample integrity. Alternatively, you may visit our facility in Dubai Healthcare City.
3. How long does it take to get results?
Results are typically ready within 3–4 weeks, including a complimentary post‑test clinical guidance call with our genetics specialist.
UAE Regulatory & Data Privacy Adherence
This test is conducted under the regulatory framework of the Dubai Health Authority (DHA) and adheres to the following UAE laws:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring strict confidentiality of your genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing electronic health records and telemedicine.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring patient safety and informed consent.
All sample processing is performed in our ISO 9001:2015 certified laboratory under strict quality controls.
Clinical & Logistical Metadata
| Test Name | SLC35C1 Gene Glycosylation Disorder Type 2C Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | E77.8 |
| LOINC Code | 94219-3 |
| DHA Facility License & Laboratory Address | DNA Labs UAE – DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians